금융 뉴스 허브

Utilities stocks hit most oversold level in 3 years

3 Reasons MHK is Risky and 1 Stock to Buy Instead

Mohawk Industries trades at $119.51 per share and has stayed right on track with the overall market, gaining 17.2% over the last six months. At the same time, the S&P 500 has returned 16.9%.

How to make sense of 7% mortgage rates and Oracle's AI data center disruption

In this episode of Market Hang, Turney Duff and his panel of experts weigh in on Oracle's (ORCL) recent data center hiccups, high mortgage rates, McDonald's (MCD) as a market play, and more.Today's pa ...

Catalyst Watch: Jobs report, Trump AI talks, and ticking fee time for Paramount

Nike’s stock is one of the worst in the S&P 500 — and BofA says it’s not done sliding

BofA analysts say they now expect falling sales through May, dashing prior hopes for a “spring inflection.”

S&P 500 and Nasdaq Less Than 1% Off Highs

Stocks rebounded, nearing records, during Friday's session. The S&P 500 was up 0.5% at 7740.85, just 0.7% from its high of 7798.99 set Aug. 13. The Nasdaq Composite was up 0.5%, off 0.6% from its resp ...

3 Reasons to Sell CECO and 1 Stock to Buy Instead

CECO Environmental trades at $73.39 and has moved in lockstep with the market. Its shares have returned 18.2% over the last six months while the S&P 500 has gained 16.9%.

3M upgraded at Bernstein on R&D structural change, less PFAS risk than expected

Genentech's Gazyva gains indication for idiopathic nephrotic syndrome

Better Healthcare ETF: iShares Biotechnology-Focused IBB vs. Simplify's Broad PINK

iShares offers lower fees and concentrated biotech exposure with stronger 1-year returns, while Simplify provides broader healthcare diversification and a higher dividend yield.

A 10% risk-free yield? For some, yes.

This could be a bargain, especially for very high earners and those in high-tax locations.

Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation